Items where authors include "Conner, J."

Article

Tazzyman, S., Stewart, G.R., Yeomans, J. orcid.org/0000-0002-9546-3600 et al. (6 more authors) (2023) HSV1716 prevents myeloma cell regrowth when combined with bortezomib in vitro and significantly reduces systemic tumor growth in mouse models. Viruses, 15 (3). 603. ISSN 1999-4915

Kwan, A., Howard, F. orcid.org/0000-0001-9899-3079, Winder, N. et al. (13 more authors) (2022) Macrophage delivered HSV1716 is active against triple negative breast cancer. Future Pharmacology, 2 (4). pp. 444-459. ISSN 2673-9879

Howard, F. orcid.org/0000-0001-9899-3079, Conner, J., Danson, S. orcid.org/0000-0002-3593-2890 et al. (1 more author) (2022) Inconsistencies in modeling the efficacy of the oncolytic virus HSV1716 reveal potential predictive biomarkers for tolerability. Frontiers in Molecular Biosciences, 9. 889395.

Howard, F.H.N. orcid.org/0000-0001-9899-3079, Al‐Janabi, H., Patel, P. et al. (11 more authors) (2022) Nanobugs as drugs: bacterial derived nanomagnets enhance tumor targeting and oncolytic activity of HSV‐1 virus. Small, 18 (13). 2104763. ISSN 1613-6810

Muthana, M., Kennerley, A.J., Hughes, R. et al. (12 more authors) (2015) Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting. Nature Communications, 6. 8009.